Insulin Pumps (External)

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

• Study Reliability and Reporting Limitations
• Disclaimers
• Data Interpretation & Reporting Level
• Quantitative Techniques & Analytics
• Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. Industry Overview

• Current and Future Analysis
• Competitive Scenario
• Tough Ground for New Entrants
• Major Growth Drivers
• Developments in Insulin Delivering Technologies
• ICR: A Key Factor to Success
• Emergence of Combination Products
• Expiry of Warranty Provides New Opportunities
• Customer Satisfaction
• Issues and Trends
• Debate On Superiority of Pump Therapy Over MDI Continues
• Complicated Software Poses a Threat
• Lack of Awareness Limits Intensive Insulin Therapy Practice
• Teenagers Outdo Adults in Controlling Diabetes

2. Diabetes & Insulin - An Abstract

• Diabetes
• A Fatal Disease
• Table 1: Leading Countries Worldwide in Terms of Diabetes Population (includes corresponding Graph/Chart)
• Types of Diabetes
• Long Term Complications of Diabetes
• Testing Sugar Levels: Easy and Accurate
• Key Drug Classes of Diabetes
• Insulin
• Pancreas: The Main Source of Insulin in Human Body
• Types of Insulin
• Insulin Delivery Systems
• a. Syringes
• b. Insulin Pens
• c. Jet Injectors
• d. Tablets
• e. External Insulin Pumps
• Insulin Delivery Technologies

3. Product Overview

• An Introduction to Insulin Pumps
• Insulin Pump - A Replica of Pancreas
• Advantages
• More Accurate and Consistent
• Enhances Blood Sugar Control in Pediatric Patients
• A Peek into Past
• Components of Insulin Pump
• How Does an Insulin Pump Work?
• Insulin Pump Delivery Rates
• Guidelines for Insulin Pump Usage
• Risks Involved in the Usage of Insulin Pumps
• Lantus: A Threat to Insulin Pump Manufacturers
• Training: A Crucial Aspect in Insulin Pump Therapy
• Centers for Medicare & Medicaid Services (CMS): Funding Organizations
• Implantable Insulin Pumps: Emerging Technology in Insulin Pump Market

4. Product Innovations/Introductions

• ROCHE Launches Accu-Chek Spirit
• Smith Medical Launches Cozmo in China
• Industrial Scholar Devises Wristwatch Insulin Pump
• Medtronic Unveils Arabic Language Insulin Pump
• Medtronic Launches New Diabetes Monitoring System
• Debiotech Unveils Miniaturized Insulin Nanopump™
• Roche Diagnostics Introduces New Insulin Pump System
• Medtronic Releases New Diabetes Device
• SpectRx Unveils SimpleChoice Infusion Sets
• Nipro Diabetes Unveils Amigo ® Insulin Pump
• SpectRx Introduces New Series of Insulin Pumps
• New OmniPod Insulin Management System from Insulet
• New1250 Insulin Pumps from Animas
• Smiths Medical Launches Insulin Pumps in Germany
• Becton, Dickinson Unveils the First Intelligent Pump
• Medtronic Rolls Out New Pump Systems
• Accu-Science Launches New Insulin Pumps in Ireland
• New Insulin Pump Infusion Sets from SpectRx
• Roche Expands Accu-Chek Product Line
• Cozmo® Insulin Pump Technology from Smiths
• Medtronic Unveils Paradigm 512 and 712
• SpectRx Launches Disposable Infusion Set

5. Recent Industry Activity

• Animas Partners with DexCom
• Insulet Inks Agreement with DexCom
• Medtronic Partners with LifeScan
• Phluid Corporation Inks Agreement with Syprosoft
• Insulet Partners with Flextronics
• Medco Absorbs PolyMedica
• Debiotech Allies with STMicroelectronics
• NiliMedix Seeks FDA Approval
• NiliMedix Attains CE Approval
• NationsHealth Pockets Diabetes Care & Education
• SpectRx, Inc. Divests Insulin Pump Business
• SpectRx Sells SimpleChoice Business
• Medtronic Obtains FDA Clearance for MiniMed Paradigm® Diabetes Device
• FDA Approves Smiths Medical' s Updated CozMore System
• Matria Healthcare Acquires CorSolutions
• Johnson & Johnson Acquires Animas
• MiniMed Signs an Agreement with Smiths Medical
• Starbridge Collaborates with Medical House Products
• Medtronic Extends Educational Support for Diabetes Management
• ADA Calls the Government to Rescind Cuts to Maine Care
• Insulet Partners with Solectron
• Animas' IR 1250 Pump Gains FDA Approval
• Nilimed Awaits Grant from Chief Scientist
• Animas Recalls Its Newly Released Insulin Pumps
• Animas Teams Up with Debiotech
• Deltec Turns Into Smiths Medical
• Smiths' Products Gain FDA Approval
• Cigna Detaches Dana
• Smiths Collaborates with TheraSense
• Animas' Insulin Pumps Receive Nod from Health Canada
• Smiths Partners with Abbott
• Cleo 90 Receives FDA Approval
• Animas' Insulin Pumps Receives the Approval of Israeli Government
• Animas Relocates Headquarters
• FDA Bans Disetronic in the US
• Animas Expands
• Medtronic Retracts Infusion Sets
• Animas Acquires Cygnus
• Novo Nordisk Signs an Agreement with Medtronic
• Roche Acquires Disetronic

6. Focus on Key Players

• Animas Corporation (USA)
• Debiotech S.A. (Switzerland)
• Disetronic Medical Systems AG (Switzerland)
• Insulet Corporation (USA)
• Matria Healthcare, Inc. (USA)
• Medtronic Diabetes (USA)
• Nilimedix Ltd (Israel)
• Nipro Diabetes Systems (USA)
• Smiths Medical MD, Inc. (USA)
• Sooil Development Co. Ltd. (Korea)
• Starbridge Systems Ltd. (UK)

7. Global Market Perspective

• Table 2: World Recent Past, Current & Future Market Analysis for Insulin Pumps (External) by Geographic Region - US, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 3: World Long-term Projections for Insulin Pumps (External) by Geographic Region - US, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 4: World 10-Year Perspective for Insulin Pumps by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe, and Rest of World Markets for2003, 2008 & 2012 (includes corresponding Graph/Chart)

III. MARKET

1. The United States

• A. Market Analysis
  • Current and Future Analysis
  • A Major Market for Insulin Delivery Devices
  • Product Innovations/Developments
  • Strategic Corporate Developments
  • Key Players
  • Animas Corporation
  • Becton, Dickinson & Company
  • Insulet Corporation
  • Matria Healthcare, Inc.
  • Medtronic Diabetes
  • Nipro Diabetes Systems
  • PolyMedica Corp
  • Smiths Medical MD, Inc.
• B. Market Analytics
  • Table 5: US Recent Past, Current & Future Market Analysis for Insulin Pumps (External) - Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 6: US Long-term Projections for Insulin Pumps (External) - Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

2. Europe

• A. Market Analysis
  • Current and Future Analysis
• B. Market Analytics
  • Table 7: European Recent Past, Current & Future Market Analysis for Insulin Pumps (External) by Geographic Region - France, Germany, UK, Italy, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 8: European Long-term Projections for Insulin Pumps (External) by Geographic Region - France, Germany, UK, Italy, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 9: European 10-Year Perspective for Insulin Pumps by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, UK, Italy, Spain,and Rest of Europe Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

2a. France

• Market Analysis
• Table 10: French Recent Past, Current & Future Market Analysis for Insulin Pumps (External) - Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 11: French Long-term Projections for Insulin Pumps (External) - Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

2b. Germany

• A. Market Analysis
  • Current and Future Analysis
  • Product Launch
• B. Market Analytics
  • Table 12: German Recent Past, Current & Future Market Analysis for Insulin Pumps (External) - Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 13: German Long-term Projections for Insulin Pumps (External) - Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

2c. The United Kingdom

• A. Market Analysis
  • Current and Future Analysis
  • INPUT (The Insulin Pump Therapy Group)
  • NICE (National Institute of Clinical Excellence)
  • Strategic Corporate Developments
  • Starbridge Systems Ltd. - A Key Player
• B. Market Analytics
  • Table 14: United Kingdom Recent Past, Current & Future Market Analysis for Insulin Pumps (External) - Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 15: United Kingdom Long-term Projections for Insulin Pumps (External) - Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

2d. Italy

• A. Market Analysis
  • Table 16: Italian Recent Past, Current & Future Market Analysis for Insulin Pumps (External) - Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 17: Italian Long-term Projections for Insulin Pumps (External) - Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

2e. Spain

• Market Analysis
• Table 18: Spanish Recent Past, Current & Future Market Analysis for Insulin Pumps (External) - Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 19: Spanish Long-term Projections for Insulin Pumps (External) - Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

2f. Rest of Europe

• A. Market Analysis
  • Current and Future Analysis
  • Product Innovations/Developments
  • Strategic Corporate Developments
  • Key Players
  • Debiotech S.A. (Switzerland)
  • Disetronic Medical Systems AG (Switzerland)
• B. Market Analytics
  • Table 20: Rest of Europe Recent Past, Current & Future Market Analysis for Insulin Pumps (External) - Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 21: Rest of Europe Long-term Projections for Insulin Pumps (External) - Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

3. Rest of World

• A. Market Analysis
  • Current and Future Analysis
  • Review of Select Countries/Regions
  • Canada
  • Asia-Pacific
  • Product Launches
• Strategic Corporate Developments
  • Key Players
  • Nilimedix Ltd (Israel)
  • Sooil Development Co. Ltd. (Korea)
• B. Market Analytics
  • Table 22: Rest of World Recent Past, Current & Future Market Analysis for Insulin Pumps by Product - External Insulin Pumps Market Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 23: Rest of World Long-term Projections for Insulin Pumps by Product - External Insulin Pumps Market Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

COMPETITIVE LANDSCAPE